Cite

HARVARD Citation

    DeAngelo, D. et al. (2019). Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia. Leukemia research. p. . [Online]. 
  
Back to record